Congressmembers Langworthy, Schrier Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
forward that modernizes the biosimilar approval pathway. We applaud Representatives Langworthy and Schrier for introducing this bipartisan, commonsense